Kera Capital Partners »

4d Molecular Therapeutics In shares owned by Kera Capital Partners

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Kera Capital Partners from 13F filings

Historical chart of Kera Capital Partners investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Kera Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Kera Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $209k 24k 8.69
2025-06-30 $89k 24k 3.71

More positions owned by Kera Capital Partners

NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Capital Group Growth Etf Shs Creation Uni (CGGR)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Robinhood Mkts Com Cl A (HOOD)
Coinbase Global Com Cl A (COIN)
Corning Incorporated (GLW)
Vertiv Holdings Com Cl A (VRT)
Intel Corporation (INTC)
Arista Networks Com Shs (ANET)
Broadcom (AVGO)
Amazon (AMZN)
Nu Hldgs Ord Shs Cl A (NU)

View all positions for Kera Capital Partners

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Vanguard Group
Novo A/S
Henderson Group
Federated Investors
Millennium Management
Armistice Capital
Morgan Stanley
Geode Capital Management
State Street Corporation
Assenagon Asset Management
Two Sigma Advisers

View all funds holding 4d Molecular Therapeutics In